Skip to main content
YESCARTA is a prescription medicine used to treat large B-cell lymphoma, a type of non-Hodgkin lymphoma, when your first treatment did not work or your cancer returned within a year of first treatment, OR when at least two kinds of treatment have failed to control your cancer. YESCARTA is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells Read Less

NOW APPROVED

YESCARTA is the first CAR T-cell therapy approved for patients whose first treatment did not work or whose cancer returned within a year of first treatment.

Considering CAR T-cell therapy with YESCARTA

This is the
power of “YES”

YESCARTA is a prescription medicine used to treat large B-cell lymphoma, a type of non-Hodgkin lymphoma, when your first treatment did not work or your cancer returned within a year of first treatment, OR when at least two kinds of treatment have failed to control your cancer. YESCARTA is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells.

It all starts with the fighter within

YESCARTA is a different kind of cancer treatment called CAR T-cell therapy. It uses your own cells to give you another chance against large B-cell lymphoma.

See what CAR T can do

I was intrigued by a therapy that would use my own immune system to fight cancer.

HUMBERTO
A real patient who received YESCARTA after multiple treatments did not control their cancer. Results and side effects may vary. Featured patients are sponsored by Kite.

Over 6800 patients have been
treated with YESCARTA*

Thousands of patients have said "YES" to YESCARTA. You could be one of them.

*As of March 16, 2022, this number includes global commercial and clinical trial data in patients with LBCL whose first treatment did not work or their cancer returned within a year of first treatment, OR when at least two kinds of treatment failed to control their cancer.

See if YESCARTA is right for you

Need resources and support?

Find YESCARTA resources and personalized support for any stage of your treatment journey.

Get the most out of your next doctor’s visit

Considering YESCARTA? This list of useful discussion topics will help guide a productive conversation with your oncologist.

IMPORTANT SAFETY INFORMATION What is the most important information I should know about YESCARTA?

YESCARTA may cause side effects that are life-threatening and can lead to death. Call or see your healthcare provider or get emergency help right away if you get any of the following:

  • Fever (100.4°F/38°C or higher)
  • Difficulty breathing
  • Chills or shaking chills
  • Confusion
  • Dizziness or lightheadedness
  • Severe nausea, vomiting, or diarrhea
  • Fast or irregular heartbeat
  • Severe fatigue or weakness

It is important to tell your healthcare provider that you received YESCARTA and to show them your YESCARTA Patient Wallet Card. Your healthcare provider may give you other medicines to treat your side effects.

Before getting YESCARTA, tell your healthcare provider about all your medical problems, including if you have or have had:

  • Neurologic problems (such as seizures, stroke, or memory loss)
  • Lung or breathing problems
  • Heart problems
  • Liver problems
  • Kidney problems
  • A recent or active infection

Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive YESCARTA?

  • Since YESCARTA is made from your own white blood cells, your blood will be collected by a process called “leukapheresis” (loo-kah-fur-ee-sis), which will concentrate your white blood cells.
  • Your blood cells will be sent to a manufacturing center to make your YESCARTA.
  • Before you get YESCARTA, you will get 3 days of chemotherapy to prepare your body.
  • When your YESCARTA is ready, your healthcare provider will give it to you through a catheter placed into your vein (intravenous infusion). The infusion usually takes less than 30 minutes.
  • You will be monitored where you received your treatment daily for at least 7 days after the infusion.
  • You should plan to stay close to the location where you received your treatment for at least 4 weeks after getting YESCARTA. Your healthcare provider will help you with any side effects that may occur.
  • You may be hospitalized for side effects and your healthcare provider will discharge you if your side effects are under control, and it is safe for you to leave the hospital.
  • Your healthcare provider will want to do blood tests to follow your progress. It is important that you do have your blood tested. If you miss an appointment, call your healthcare provider as soon as possible to reschedule.

What should I avoid after receiving YESCARTA?

  • Do not drive, operate heavy machinery, or do other dangerous things for 8 weeks after you get YESCARTA because the treatment can cause sleepiness, confusion, weakness, and temporary memory and coordination problems.
  • Do not donate blood, organs, tissues, or cells for transplantation.

What are the possible or reasonably likely side effects of YESCARTA?

The most common side effects of YESCARTA include:

  • Fever (100.4°F/38°C or higher)
  • Low white blood cells (can occur with a fever)
  • Low red blood cells
  • Low blood pressure (dizziness or lightheadedness, headache, feeling tired, short of breath)
  • Fast heartbeat
  • Confusion
  • Difficulty speaking or slurred speech
  • Nausea
  • Diarrhea

These are not all the possible side effects of YESCARTA. Call your healthcare provider about any side effects that concern you. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.

Please see the Important Facts, including IMPORTANT WARNINGS.

APPROVED USE

YESCARTA is a prescription medicine used to treat large B-cell lymphoma, a type of non-Hodgkin lymphoma, when your first treatment did not work or your cancer returned within a year of first treatment, OR when at least two kinds of treatment have failed to control your cancer. YESCARTA is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells.